Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,129,863
+$263,440 QoQ
Shares Held
942
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#3,020
of 4,605 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Zuckerman Investment Group, LLC holds $39,445,591 across 6 Drug Manufacturers - General names. LLY ranks #4 (2.9% of the industry book) .
All Filings in LLY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,129,863 | 942 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $866,423 | 942 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,012,348 | 942 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $718,746 | 942 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $722,624 | 927 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $743,319 | 900 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $753,472 | 976 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $874,422 | 987 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $906,285 | 1,001 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $778,737 | 1,001 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $580,588 | 996 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $478,045 | 890 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $456,317 | 973 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $339,642 | 989 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $377,912 | 1,033 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $279,051 | 863 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $279,810 | 863 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $247,137 | 863 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $238,377 | 863 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||